Afuco™ Anti-Human PDGFRB ADCC Therapeutic Antibody (IMC-2C5), ADCC Enhanced
Anti-PDGFRB ADCC Enhanced Antibody (IMC-2C5) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-2C5 binds to both human and mouse PDGFRβ. And it is involved in the treatment of a broad range of human cancers.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-678CL |
Pricing | Inquiry |
Host | Human |
Target | PDGFRB |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | Inhib, FuncS |
Storage |
|